FBInvestor
Stocks / 4d Molecular Therapeutics In
Institutional Ownership

4d Molecular Therapeutics In

CUSIP 35104E100COMFDMTQ1 2026

Dividends

Dividends-per-share are sourced from SEC XBRL filings. Either this issuer doesn't declare a common dividend, or it isn't ingested yet (we cover the top issuers first).

Coming soon